Literature DB >> 9500384

A new strategy of muscle transposition for treatment of shoulder deformity caused by obstetric brachial plexus palsy.

D C Chuang1, H S Ma, F C Wei.   

Abstract

Cross-innervation (caused by misdirection of regenerated axons), muscular imbalance (caused by muscle paresis or earlier recovery), and growth are the three main causes of shoulder deformity due to obstetric brachial plexus palsy. If perioperative studies demonstrate the existence of muscle recovery by cross-innervation, a new strategy of muscle transposition to minimize the influence of cross-innervation is used. Release of antagonistic muscles (pectoralis major and teres major muscles) and augmentation of paretic muscles (transferring teres major to the infraspinatus muscle, reinserting both ends of the clavicular part of the pectoralis major muscle laterally) are performed for reconstruction. Since 1993, 29 patients having shoulder deformity caused by obstetric brachial plexus palsy underwent reconstruction utilizing this strategy of muscle transposition. The timing for the reconstruction was at an average of 8.5 years (range, 4 to 21 years). The average shoulder abduction following the muscle transposition was 151 degrees (i.e., average gain 104 percent, or 77 degrees) and that of external rotation was 72 degrees (average gain 200 percent, or 48 degrees). Compared with the patients who had no surgery for shoulder deformity caused by obstetric brachial plexus palsy and early nerve surgery for the infant obstetric brachial plexus palsy, the results of the strategy seem to be significantly impressive.

Entities:  

Mesh:

Year:  1998        PMID: 9500384     DOI: 10.1097/00006534-199803000-00015

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  8 in total

1.  Morphometric analysis of the effect of scapula stabilization on obstetric brachial plexus paralysis patients.

Authors:  Julia K Terzis; Dimitrios Karypidis; Ricardo Mendoza; Zinon T Kokkalis; Norou Diawara
Journal:  Hand (N Y)       Date:  2014-09

2.  The prevalence, rate of progression, and treatment of elbow flexion contracture in children with brachial plexus birth palsy.

Authors:  Lindsey C Sheffler; Lisa Lattanza; Yolanda Hagar; Anita Bagley; Michelle A James
Journal:  J Bone Joint Surg Am       Date:  2012-03-07       Impact factor: 5.284

3.  Conjoint muscle transfer and subscapularis slide in brachial plexus birth palsy: Clinical outcomes in shoulder functions.

Authors:  Sanjay Maurya; P S Bhandari; Surya Chaitanya
Journal:  Med J Armed Forces India       Date:  2020-08-05

4.  Does primary brachial plexus surgery alter palliative tendon transfer surgery outcomes in children with obstetric paralysis?

Authors:  Atakan Aydın; Ahmet Biçer; Türker Özkan; Berkan Mersa; Safiye Özkan; Zeynep Hoşbay Yıldırım
Journal:  BMC Musculoskelet Disord       Date:  2011-04-13       Impact factor: 2.362

5.  Clinical outcome of shoulder muscle transfer for shoulder deformities in obstetric brachial plexus palsy: A study of 150 cases.

Authors:  Mukund R Thatte; Mandar V Agashe; Aamod Rao; Chasanal M Rathod; Rujuta Mehta
Journal:  Indian J Plast Surg       Date:  2011-01

6.  Postparalysis facial synkinesis: clinical classification and surgical strategies.

Authors:  David Chwei-Chin Chuang; Tommy Nai-Jen Chang; Johnny Chuieng-Yi Lu
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-04-07

7.  Obstetric paralysis: anterior arthroscopic release of the shoulder and transfer of the latissimus dorsi using a homologous graft.

Authors:  Alberto Naoki Miyazaki; Caio Santos Checchia; Sergio Luiz Checchia; Marcelo Fregoneze; Pedro Doneux Santos; Guilherme do Val Sella
Journal:  Rev Bras Ortop       Date:  2016-05-03

8.  Does preoperative abduction value affect functional outcome of combined muscle transfer and release procedures in obstetrical palsy patients with shoulder involvement?

Authors:  Atakan Aydin; Turker Ozkan; Defne Onel
Journal:  BMC Musculoskelet Disord       Date:  2004-08-03       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.